Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Jan 27, 2017
Clinical News
Seciera: Ph III Emerald data
...to week 12 vs. vehicle-treated controls (p<0.0001). Sun gained Seciera through its acquisition of the
Ocular Technologies S.a.r.l.
...
Read More
Items per page:
10
1 - 1 of 1
BioCentury
|
Jan 27, 2017
Clinical News
Seciera: Ph III Emerald data
...to week 12 vs. vehicle-treated controls (p<0.0001). Sun gained Seciera through its acquisition of the
Ocular Technologies S.a.r.l.
...
Read More
Items per page:
10
1 - 1 of 1
Previous page
Next page